Grifols is a global healthcare company. Grifols operates in three segments: Bioscience, Hospital, and Diagnostic. The Bioscience segment engages in the research, development, production, and commercialization of plasma derivates. The Diagnostic segment focuses on researching, developing, manufacturing, and marketing diagnostics products for laboratory analysis, including products for hospital blood banks and transfusion centers.